PCN29 COMPARATIVE EFFICACY OF NIVOLUMAB VERSUS RELEVANT TREATMENTS IN PRETREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): A SYSTEMATIC LITERATURE REVIEW AND INDIRECT TREATMENT COMPARISON OF RANDOMIZED CONTROLLED TRIALS (RCTS)

Comparative efficacy and safety of nivolumab (nivo) vs relevant treatments (txs) in pretreated squamous (SQ) advanced non-small cell lung cancer (aNSCLC): Results from a systematic literature review (SLR) and indirect treatment comparisons (ITCs) of randomized controlled trials (RCTs)

European Journal of Cancer ◽

10.1016/s0959-8049(17)30525-7 ◽

2017 ◽

Vol 72 ◽

pp. S136

Author(s):

W.E.E. Eberhardt ◽

J. Vanderpuye-Orgle ◽

M. Reck ◽

D. Waterhouse ◽

B. Smiechowski ◽

...

Keyword(s):

Lung Cancer ◽

Literature Review ◽

Small Cell ◽

Controlled Trials ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Small Cell Lung ◽

Randomized Controlled ◽

Indirect Treatment ◽

Treatment Comparisons

Comparative efficacy and safety of nivolumab (nivo) vs relevant treatments (txs) in pretreated non-squamous (NSQ) advanced non-small cell lung cancer (aNSCLC): Results from a systematic literature review (SLR) and indirect treatment comparisons (ITCs) of randomized controlled trials (RCTs)

European Journal of Cancer ◽

10.1016/s0959-8049(17)30524-5 ◽

2017 ◽

Vol 72 ◽

pp. S136

Author(s):

A. Shrestha ◽

J.R. Penrod ◽

M. Reck ◽

D.R. Spigel ◽

B. Smiechowski ◽

...

Keyword(s):

Lung Cancer ◽

Literature Review ◽

Small Cell ◽

Controlled Trials ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Small Cell Lung ◽

Randomized Controlled ◽

Indirect Treatment ◽

Treatment Comparisons

Indirect Treatment Comparison of Lurbinectedin vs. Other Second-Line Treatments for Small-Cell Lung Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2021.10.194 ◽

2022 ◽

Vol 112 (2) ◽

pp. e18

Author(s):

B. Rengarajan ◽

R. Hanvesakul ◽

C. Stack ◽

F. Wilson ◽

J. Park ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Second Line ◽

Small Cell Lung ◽

Indirect Treatment Comparison ◽

Treatment Comparison ◽

Indirect Treatment

PCN18 INDIRECT TREATMENT COMPARISON OF ALECTINIB VS. BRIGATINIB IN ALK+ NON-SMALL CELL LUNG CANCER (NSCLC)

Value in Health ◽

10.1016/j.jval.2019.04.142 ◽

2019 ◽

Vol 22 ◽

pp. S59

Author(s):

W. Wong ◽

D. Sheinson

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Indirect Treatment Comparison ◽

Treatment Comparison ◽

Indirect Treatment

Role of pemetrexed in advanced non-small-cell lung cancer: meta-analysis of randomized controlled trials, with histology subgroup analysis

Current Oncology ◽

10.3747//co.19.891 ◽

2012 ◽

Vol 19 (1) ◽

Author(s):

K. Alsaleh ◽

C. Quinton ◽

P. M. Ellis

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Subgroup Analysis ◽

Meta Analysis ◽

Small Cell ◽

Controlled Trials ◽

Small Cell Lung ◽

The benefits and risks of CTLA4 inhibitor plus PD1/PDL1 inhibitor in stage IIIB/IV non‐small cell lung cancer: A systematic analysis and meta‐analysis based on randomized controlled trials

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.13465 ◽

2021 ◽

Author(s):

Qiangyun Liu ◽

Zige Fang ◽

Miaowen Liu ◽

Ruoxin Xu ◽

Fengming Yi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Controlled Trials ◽

Small Cell Lung ◽

Systematic Analysis ◽

Effectiveness of neoadjuvant chemotherapy on the survival outcomes of patients with resectable non-small-cell lung cancer: A meta-analysis of randomized controlled trials

Surgical Oncology ◽

10.1016/j.suronc.2021.101590 ◽

2021 ◽

pp. 101590

Author(s):

Yunfeng Zhang ◽

Xiayun Hu ◽

Dapeng Liu ◽

Rui Wang ◽

Xin Sun ◽

...

Keyword(s):

Lung Cancer ◽

Neoadjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Survival Outcomes ◽

Controlled Trials ◽

Small Cell Lung ◽

The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials

ESMO Open ◽

10.1016/j.esmoop.2021.100124 ◽

2021 ◽

Vol 6 (3) ◽

pp. 100124

Author(s):

A. Galvano ◽

V. Gristina ◽

U. Malapelle ◽

P. Pisapia ◽

F. Pepe ◽

...

Keyword(s):

Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Controlled Trials ◽

Prognostic Impact ◽

Small Cell Lung ◽

First Line ◽

Randomized Controlled ◽

Mutational Burden ◽

Tumor Mutational Burden

Risk profile of bevacizumab in patients with non-small cell lung cancer: A meta-analysis of randomized controlled trials

Acta Oncologica ◽

10.3109/0284186x.2011.631579 ◽

2011 ◽

Vol 51 (2) ◽

pp. 151-156 ◽

Cited By ~ 9

Author(s):

Chao Cao ◽

Jianmiao Wang ◽

Hansvin Bunjhoo ◽

Yongjian Xu ◽

Huijuan Fang

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Risk Profile ◽

Small Cell ◽

Controlled Trials ◽

Small Cell Lung ◽

Efficacy and safety of docetaxel for advanced non-small-cell lung cancer: a meta-analysis of Phase III randomized controlled trials

OncoTargets and Therapy ◽

10.2147/ott.s85648 ◽

2015 ◽

pp. 2023 ◽

Cited By ~ 18

Author(s):

Xuan He ◽

Yuanming Li ◽

Ji Wang

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Phase Iii ◽

Controlled Trials ◽

Efficacy And Safety ◽

Small Cell Lung ◽